Alzheimer’s Disease: Fat’s Link to Brain Damage
“`html
Obesity Linked to Accelerated Alzheimer’s Development Through Cellular Messengers
Table of Contents
New research from Houston Methodist and The Ohio state University Wexner medical Center identifies a link between obesity, altered cellular dialog, and the accelerated clumping of amyloid-β, a hallmark of Alzheimer’s disease.
The Connection Between Obesity and Alzheimer’s
Obesity is increasingly recognized as a notable modifiable risk factor for dementia, notably Alzheimer’s disease. Recent studies have underscored this connection, prompting researchers to investigate the underlying mechanisms. According to the Alzheimer’s Association, more than 6 million Americans are living with Alzheimer’s disease in 2024 Alzheimer’s association Facts and Figures.
Researchers at Houston Methodist and The Ohio State University have discovered that the way cells communicate differs in individuals with obesity compared to lean individuals, and this difference impacts the progression of Alzheimer’s disease. Specifically, the lipid cargo carried by extracellular vesicles – tiny messengers traveling throughout the body – plays a crucial role.
Extracellular Vesicles and Amyloid-β Clumping
The study focused on extracellular vesicles (EVs), membrane-bound particles involved in cell-to-cell communication. These vesicles are capable of crossing the blood-brain barrier, delivering their cargo directly to brain cells. Researchers examined evs from both obese and lean individuals, analyzing the lipids they contained.
They found that the lipid composition of evs differed between the two groups. These differences, in turn, affected the rate at wich amyloid-β proteins clumped together in laboratory models. Amyloid-β plaques are a key pathological feature of Alzheimer’s disease, and their accumulation is thought to contribute to neuronal damage and cognitive decline.
“We found that the lipid cargo of these cell messengers differs between people with obesity and lean individuals, and that the presence and levels of specific lipids that differed between the groups changed how quickly amyloid-β clumped together in laboratory models,” explained Dr. C. Michael Wong, corresponding author and director of the T. T. & W. F. Chao Center for BRAIN at Houston Methodist.
Research Methodology and findings
The research team utilized both mouse models and human body fat samples to investigate the role of EVs in alzheimer’s disease development. They observed that EVs from obese individuals promoted faster amyloid-β aggregation compared to EVs from lean individuals.
The study involved collaboration between researchers from multiple institutions, including:
- houston Methodist
- The Ohio State University’s Wexner Medical Center
- University of Texas Health Science Center at San Antonio
Key researchers involved in the study included C. Michael Wong,.D., who provided leadership in experimental design and cross-institution coordination, along with Michael Chan, Shaohua Qi, Bill Chan, dharti Shantaram, Xilal Rima, Eduardo Reategui, Willa Hsueh, and Xianlin Han.
Implications and Future Research
The findings suggest that targeting EVs and disrupting their communication pathways could potentially reduce the risk of Alzheimer’s disease in individuals with obesity. Researchers believe that developing therapies to prevent or slow the build-up of toxic proteins like amyloid-β in at-risk individuals is a crucial next step.
Future research will focus on identifying specific drug targets within the EV communication pathway. The goal is to develop interventions that can modulate EV lipid cargo and mitigate the harmful effects on amyloid-β aggregation.
